The forecast for pancreas malignant neoplasms mortality in Japan shows a consistent year-on-year increase from 2024 to 2028, with values rising from 41.62 thousand deaths in 2024 to 45.5 thousand deaths in 2028. In 2023, the actual value was 40.7 thousand deaths, indicating an upward trend in the mortality rate associated with pancreatic cancer. The year-on-year growth between 2024 and 2025 is approximately 2.38%, and from 2025 to 2026, it is around 2.28%. The trend continues with values increasing at a similar pace annually, resulting in an approximate compound annual growth rate (CAGR) of 2.33% over the five-year period.
Future trends to watch for include advances in medical treatments and early detection technologies, which may alter the forecasted trajectories. Additionally, lifestyle changes and public health initiatives aimed at reducing risk factors for pancreatic cancer could impact mortality rates. Trends in healthcare funding and resource allocation will also play a critical role in shaping these outcomes.
